This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Prevention of Iron Deficiency in 2nd Year of Life

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2007 by Soroka University Medical Center.
Recruitment status was:  Not yet recruiting
Information provided by:
Soroka University Medical Center Identifier:
First received: May 24, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted
Healthy babies(age 8-18 months) following a routine blood count, with no anemia or iron deficiency, will be randomly placed in two groups. Group 1 will receive a 3 months preventive dose of an iron preparation (Ferripel 3 iron polysaccharide complex). Group 2 will be followed up as a control group. Following a nutritional questionnair, parents of all babies will receive instruction regarding appropriate nutrition in the 2nd year of life. A follow-up blood count will be taken from all participating babies 3 months after recruitment. The study aims to evaluate effectiveness of iron supplementation in the 2nd year of life. The hypothesis is that babies who receive iron supplementation in the 2nd year of life are less likely to develop iron deficiency or anemia.

Condition Intervention Phase
Iron Deficiency Anemia Drug: Ferripel-3 - iron polysaccharide complex for prevention Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Effectiveness of Iron Supplementation in the Second Year of Life for Prevention of Iron Deficiency

Resource links provided by NLM:

Further study details as provided by Soroka University Medical Center:

Study Start Date: May 2007

Ages Eligible for Study:   8 Months to 18 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy babies without iron deficiency

Exclusion Criteria:

  • Babies with iron deficiency or chronic diseases, premature babies and babies with hereditary hematological disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00479102

Contact: Hanna Shalev, MD 972-52-8504058

Clalit Health Services Child Health Center Not yet recruiting
Rahat, Israel
Contact: Hanna Shalev, MD    972-52-8504058   
Sponsors and Collaborators
Soroka University Medical Center
Principal Investigator: Hanna Shalev, MD Clalit Health Services
  More Information Identifier: NCT00479102     History of Changes
Other Study ID Numbers: sor448707ctil
Study First Received: May 24, 2007
Last Updated: May 24, 2007

Keywords provided by Soroka University Medical Center:
Iron supplementation

Additional relevant MeSH terms:
Anemia, Iron-Deficiency
Anemia, Hypochromic
Hematologic Diseases
Iron Metabolism Disorders
Metabolic Diseases
Trace Elements
Growth Substances
Physiological Effects of Drugs processed this record on September 21, 2017